Suppr超能文献

塞来昔布-聚乙烯吡咯烷酮无定形分散体的稳定性和溶解性:分子视角

Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective.

作者信息

Gupta Piyush, Kakumanu Vasu Kumar, Bansal Arvind K

机构信息

Department of Pharmaceutical Technology (Formulations), National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, Phase X, SAS Nagar, Punjab 160 062, India.

出版信息

Pharm Res. 2004 Oct;21(10):1762-9. doi: 10.1023/b:pham.0000045226.42859.b8.

Abstract

PURPOSE

The purpose of the current study is to evaluate the solubility advantage offered by celecoxib (CEL) amorphous systems and to characterize and correlate the physical and thermodynamic properties of CEL and its amorphous molecular dispersions containing poly(vinylpyrrolidone) (PVP).

METHODS

The measurement of crystalline content, glass transition temperatures, and enthalpy relaxation was performed using differential scanning calorimetry. Solubility and dissolutions studies were conducted at 37 degrees C to elucidate release mechanisms. Further, the amorphous systems were characterized by polarized light microscopy and X-ray powder diffraction studies.

RESULTS

The PVP content has a prominent effect on the stability and solubility profiles of amorphous systems. A dispersion of 20% w/w PVP with CEL resulted in a maxima in terms of solubility enhancement and lowering of relaxation enthalpy. The release of drug from amorphous molecular dispersions was found to be drug-dependent and independent of the carrier.

CONCLUSIONS

The solubility enhancement and enthalpy relaxation studies with respect to PVP concentration helped in a better prediction of role of carrier and optimization of concentration in the use of solid dispersions or amorphous systems. The drug release mechanism is drug-controlled rather than carrier-controlled.

摘要

目的

本研究旨在评估塞来昔布(CEL)无定形体系所提供的溶解性优势,并对CEL及其含聚乙烯吡咯烷酮(PVP)的无定形分子分散体的物理和热力学性质进行表征及关联。

方法

使用差示扫描量热法测量结晶含量、玻璃化转变温度和焓松弛。在37℃下进行溶解度和溶出度研究以阐明释放机制。此外,通过偏光显微镜和X射线粉末衍射研究对无定形体系进行表征。

结果

PVP含量对无定形体系的稳定性和溶解度曲线有显著影响。CEL与20% w/w的PVP形成的分散体在溶解度增强和松弛焓降低方面达到最大值。发现药物从无定形分子分散体中的释放取决于药物,而与载体无关。

结论

关于PVP浓度的溶解度增强和焓松弛研究有助于更好地预测载体的作用以及优化固体分散体或无定形体系使用中的浓度。药物释放机制是药物控制而非载体控制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验